Figure 3.
Kaplan-Meier curve of the CLL patient material investigated in the study showing mutated (n = 79), unmutated (n = 134), and VH3-21 cases (n = 31) with a median survival of 137, 64, and 83 months, respectively.
Kaplan-Meier curve of the CLL patient material investigated in the study showing mutated (n = 79), unmutated (n = 134), and VH3-21 cases (n = 31) with a median survival of 137, 64, and 83 months, respectively.
